CSL

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Request demo

CSL — overview

About

Established in 1916, CSL is a corporate investor based in Australia. It is a global biotechnology company with a portfolio of medicines, including those that treat hemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology. The firm has three businesses namely CSL Behring, CSL Seqirus, and CSL Vifor. It also has offices in United Kingdom, United States, and Switzerland.

CSL - known decision makers (14)

Position	Location	Asset Class
Chair & Director of CSL Limited	Melbourne, Australia	PE
Chief Financial Officer	Melbourne, Australia	PE
Company Secretary and Head of Group Governance	Melbourne, Australia	PE
Chair	Melbourne, Australia	PE
Chief Executive Officer and Managing Director	Melbourne, Australia	PE

Showing 5 of 14 known decision makers CSL

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a demo to see more

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.

Request demo